I spoke during Shark Tank India, Season 5, Episode 41; pitch: HobFit. The transcript distinguishes my remarks from the founders’ and other panelists’ words.
Gaurav Dua said the founders met in 7th class; Arpit met in 2014 around graduation; reunited in 2020 during COVID. He said they wanted to start something of their own and began by helping people at home do something productive.
Gaurav said the Hobit platform helped people pursue hobbies: “Hobit ke through hum logon ki hobbies pursue karne mein madad karte the”. Its categories included dance, cooking, art and craft, and music.
The founders ran Hobit for do, dhai, teen saal, then changed the platform name from Hobit to HobFit. Gaurav described this as a pivot after observing the business and studying the market.
Gaurav said traction came only from women and fitness classes were dance-based: “but traction sirf women se generate ho pa raha tha” and “jo humare platform pe fitness classes thi, woh dance-based fitness classes thi.”
Gaurav said the market study found many fitness applications but no one working on women’s PCOD, PCOS, or hormonal disorders: “fitness ki applications toh bahut saari hain”.
I asked what year the pivot took place; no answer captured. The transcript asks, “Ye kaunsa saal tha?”
I remarked that I had heard at least 5–7 pitches about PCOS or PCOD: “Mujhe kam se kam 5-7 ne pitch kiya hoga.”
Gaurav distinguished 25,000 in total trajectory from 5,000 with active plans in the system: “Total trajectory nahi, agar main total trajectory ki baat karoon toh 25,000 hain” and “jinka plan abhi humare system ke andar active hai woh 5,000 hain.”
I asked where the other 20,000 went and proposed recovery within 4 months or lack of value as possible explanations: “Toh baaki 20,000 kahan gaye?” and “Ya toh aapki app pe itni value mil rahi hai unhe ki woh thik hi ho rahe hain 4 mahine mein” and “Ya phir unko value nahi mil rahi aur isliye woh chhod ke ja rahe hain.” The actual breakdown was not established.
Gaurav offered a possible user-compliance analogy: people may work at it for two or three months, see some benefit, then stop early, like someone stopping an antibiotic course after two days despite a three- or five-day course. He said, “jo humara antibiotic ka course hai 3 din ya 5 din ka”.
I diagnosed a user compliance issue: “Main aapko keh raha hoon user compliance ka issue hai.”
I asked whether Priyanka was a real user; no answer captured: “Ye real user hai?”
Arpit said the previous month’s revenue was 75 lakhs in November: “Last month November mein humara 75 lakhs.”
Gaurav reported almost 1,000 new paying customers in the previous month: “Almost 1,000.”
Gaurav reported an average new-customer payment of 5,500 or 6,000 average: “5,500 or 6,000 average.”
I estimated 60 lakh from new customers; remaining 15 lakh from retained users or retention; approximately 1,000 retained users proposed. Gaurav then said 300–400 users had paid retention money in the previous month: “300-400 users jinhone pichhle mahine retention ka paisa pay kara hai.”
Namita Thapar appreciated that three men were working on women’s wellness, but viewed it as a fitness and nutrition app, not a PCOS app; went out: “But at this point, it is just purely a fitness and nutrition app, and not a PCOS app. And for that reason, I am out.”
Namita said she liked seeing three men trying to do something for women’s wellness: “Aap 3 men reh ke women's wellness ke liye kuch karna chaah rahe hain, that's a very nice thing.”
I said HobFit had a high-value subscription costing thousands of rupees; Meta and Google content engines raised issues without genuinely solving them: “Humne ek high value cheez pakad li hai bechne ke liye, woh ye hazaro rupaye ki subscription.” I said I was out for that reason.
I went out and encouraged the founders to keep trying: “Is reason ke liye main aaj isse bahar hoon. But guys, keep trying, maybe you figure something out.”
The captured exchange leaves unresolved the pivot year, whether Priyanka was a real user, the true breakdown between total-trajectory and active-plan users, the definitions and periods for the revenue and customer figures, and whether the product clinically addressed PCOS or PCOD.